Invesco Dorsey Wright Healthcare Momentum ETF Rating → The Gold Grab of the Century (From Colonial Metals) (Ad) Free PTH Stock Alerts $42.27 +0.15 (+0.36%) (As of 05/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOptions ChainOwnershipRatingsSocial MediaStock AnalysisChartHoldingsOptions ChainOwnershipRatingsSocial Media Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy2.76Holdings in PTH have an aggregate rating of Moderate Buy based on 414 analyst ratings issued in the past year covering 49 companies (93.3% of the portfolio).PTH Aggregate Price Target$50.5319.54% UpsideHigh Prediction$66.76Average Prediction$50.53Low Prediction$33.16Holdings in PTH have an aggregate price target of $50.53 and a range of $33.16 to $66.76 covering 49 companies (93.3% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 PTH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.03%LLYEli Lilly and Company$777.77+1.4%5 of 5 stars2.84$757.95 -2.5%19Earnings ReportDividend Announcement4.68%IDXXIDEXX Laboratories$483.68+1.4%4 of 5 stars2.67$580.88 20.1%94.57%MEDPMedpace$402.10+0.3%5 of 5 stars2.80$443.00 10.2%54.47%ALPNAlpine Immune Sciences$64.64+0.1%2 of 5 stars2.27$50.33 -22.1%11Upcoming Earnings3.14%THCTenet Healthcare$124.10+1.4%4 of 5 stars3.00$113.19 -8.8%162.90%CORCencora$226.74+1.2%4 of 5 stars2.70$233.90 3.2%10Earnings ReportDividend AnnouncementAnalyst Revision2.86%NTRANatera$97.15-0.1%2 of 5 stars3.00$86.40 -11.1%14Upcoming Earnings2.70%REGNRegeneron Pharmaceuticals$969.97+1.2%4 of 5 stars2.70$981.71 1.2%202.68%MOHMolina Healthcare$349.85+1.9%5 of 5 stars2.40$404.90 15.7%10Positive News2.67%VERAVera Therapeutics$45.00-1.2%1 of 5 stars3.00$32.29 -28.3%8Upcoming Earnings2.63%ABBVAbbVie$162.55-0.1%4 of 5 stars2.77$174.31 7.2%13Earnings Report2.56%DVADaVita$137.79+0.7%4 of 5 stars2.33$121.33 -11.9%3Earnings ReportAnalyst Downgrade2.46%RNAAvidity Biosciences$25.39-3.6%1 of 5 stars3.00$36.86 45.2%7Upcoming EarningsInsider SellingNews Coverage2.32%ARQTArcutis Biotherapeutics$7.88-0.9%2 of 5 stars2.75$26.56 237.0%8Upcoming Earnings2.23%IDYAIDEAYA Biosciences$42.75-0.8%3 of 5 stars3.00$46.60 9.0%12Upcoming EarningsNews Coverage2.07%IBRXImmunityBio$8.26+5.8%0 of 5 stars2.00$6.00 -27.4%1Upcoming EarningsGap Up1.99%MDGLMadrigal Pharmaceuticals$217.96-7.5%5 of 5 stars2.73$356.73 63.7%11News CoverageGap Down1.95%BHVNBiohaven$41.49+0.7%3 of 5 stars3.00$52.13 25.6%8Upcoming Earnings1.91%KRYSKrystal Biotech$161.76+3.1%4 of 5 stars3.00$171.00 5.7%9Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.76%LQDALiquidia$12.84+1.2%2 of 5 stars2.60$21.00 63.6%5Upcoming EarningsPositive News1.75%ENSGThe Ensign Group$117.95+1.6%4 of 5 stars2.80$124.60 5.6%5Analyst Forecast1.68%RDNTRadNet$52.47+0.9%3 of 5 stars2.67$53.67 2.3%3Analyst Upgrade1.67%MRUSMerus$48.73+2.9%1 of 5 stars3.00$56.33 15.6%11Upcoming Earnings1.64%DYNDyne Therapeutics$25.65-2.3%4 of 5 stars3.13$37.75 47.2%8Analyst ForecastAnalyst Revision1.55%GKOSGlaukos$107.93+2.8%4 of 5 stars2.82$108.64 0.7%11Earnings ReportAnalyst UpgradeInsider Selling1.53%PCVXVaxcyte$67.52+1.7%1 of 5 stars3.00$78.50 16.3%4Upcoming Earnings1.51%SYRESpyre Therapeutics$34.24-4.3%0 of 5 stars3.00$41.00 19.7%8Upcoming Earnings1.47%APGEApogee Therapeutics$52.22-3.8%2 of 5 stars3.00$71.83 37.6%71.43%VCELVericel$49.52+5.5%1 of 5 stars3.00$46.40 -6.3%6News Coverage1.42%CRNXCrinetics Pharmaceuticals$47.66+2.5%4 of 5 stars2.92$57.58 20.8%12Upcoming EarningsAnalyst ForecastNews CoverageGap Up1.41%ITCIIntra-Cellular Therapies$71.21+0.3%5 of 5 stars2.90$90.17 26.6%10Earnings ReportAnalyst ForecastNews Coverage1.37%NUVLNuvalent$68.64-0.9%3 of 5 stars2.90$90.78 32.3%10Upcoming Earnings1.29%BPMCBlueprint Medicines$108.55+2.2%1 of 5 stars2.50$100.31 -7.6%16Analyst ForecastInsider SellingAnalyst RevisionNews Coverage1.29%KURAKura Oncology$21.07+0.3%3 of 5 stars2.88$28.28 34.2%8Earnings ReportAnalyst Forecast1.20%SWTXSpringWorks Therapeutics$45.75-1.2%1 of 5 stars3.00$68.83 50.5%6Earnings ReportAnalyst Forecast1.13%LFMDLifeMD$12.38-0.5%0 of 5 stars3.00$10.40 -16.0%51.13%ADMAADMA Biologics$6.912 of 5 stars3.25$7.88 14.0%4Upcoming Earnings1.09%HIMSHims & Hers Health$12.36+6.1%3 of 5 stars2.60$15.07 21.9%15Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.09%FATEFate Therapeutics$3.88-8.1%4 of 5 stars2.08$6.90 77.8%12Upcoming EarningsAnalyst ForecastAnalyst Revision1.03%KROSKeros Therapeutics$58.68-2.6%3 of 5 stars3.00$86.00 46.6%7Upcoming EarningsNews Coverage1.03%OCULOcular Therapeutix$5.93+2.2%4 of 5 stars3.00$17.60 196.8%5Upcoming Earnings1.00%PRAXPraxis Precision Medicines$52.40-1.4%2 of 5 stars2.80$105.80 101.9%5Upcoming Earnings0.98%UFPTUFP Technologies$253.04-1.3%1 of 5 stars2.50$238.50 -5.7%2Positive News0.97%BKDBrookdale Senior Living$7.36+0.8%2 of 5 stars2.50$7.50 2.0%20.88%SILKSilk Road Medical$20.56-1.6%2 of 5 stars2.18$22.55 9.7%110.85%ANIPANI Pharmaceuticals$66.72-1.0%5 of 5 stars3.00$80.00 19.9%4Upcoming Earnings0.81%COLLCollegium Pharmaceutical$37.30+0.8%2 of 5 stars2.60$39.00 4.6%5Upcoming Earnings0.80%LMATLeMaitre Vascular$75.90+1.2%2 of 5 stars2.71$73.83 -2.7%7Earnings ReportHigh Trading Volume0.73%FULCFulcrum Therapeutics$7.54-2.7%2 of 5 stars2.83$13.17 74.6%6Upcoming Earnings This page (NASDAQ:PTH) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
